LOS ANGELES CAPITAL MANAGEMENT LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,020,315
-13.9%
87,281
-1.1%
0.00%
-20.0%
Q2 2023$1,185,704
-35.1%
88,222
-19.9%
0.01%
-37.5%
Q1 2023$1,826,668
-23.1%
110,173
-13.7%
0.01%
-33.3%
Q4 2022$2,374,011
+30.7%
127,635
-9.8%
0.01%
+33.3%
Q3 2022$1,816,000
-29.5%
141,542
-61.5%
0.01%
-30.8%
Q2 2022$2,577,000
+31.5%
367,634
+55.5%
0.01%
+62.5%
Q1 2022$1,960,000
+0.9%
236,475
-17.6%
0.01%
+14.3%
Q4 2021$1,942,000
+58.7%
286,845
+24.2%
0.01%
+16.7%
Q3 2021$1,224,000
+22.5%
230,965
+32.9%
0.01%
+50.0%
Q2 2021$999,000
-17.4%
173,785
-52.0%
0.00%
-20.0%
Q4 2020$1,209,000
+4.8%
362,065
-6.8%
0.01%0.0%
Q3 2020$1,154,000
-47.4%
388,385
-18.2%
0.01%
-54.5%
Q2 2020$2,194,000
+80.9%
474,870
+50.7%
0.01%
+37.5%
Q1 2020$1,213,000
+203.2%
315,005
+195.6%
0.01%
+300.0%
Q4 2019$400,000
-27.0%
106,560
+3.2%
0.00%
-33.3%
Q3 2019$548,000
+50.1%
103,210
+8.7%
0.00%
+50.0%
Q2 2019$365,000
+67.4%
94,960
+122.4%
0.00%
+100.0%
Q1 2019$218,000
+165.9%
42,7000.0%0.00%0.0%
Q4 2018$82,000
-49.4%
42,700
-0.5%
0.00%0.0%
Q3 2018$162,000
+205.7%
42,900
+152.9%
0.00%
Q2 2018$53,00016,9600.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 208,189$1,726,0003.48%
FRIESS ASSOCIATES LLC 571,940$4,741,0002.53%
GABLES CAPITAL MANAGEMENT INC. 438,764$3,637,0002.28%
Prairiewood Capital, LLC 258,073$2,139,0001.50%
Quantedge Capital Pte Ltd 597,300$4,952,0001.46%
ARMISTICE CAPITAL, LLC 8,372,000$69,404,0001.34%
SummerHaven Investment Management, LLC 158,473$1,314,0000.74%
Capital Impact Advisors, LLC 99,322$823,0000.60%
EAM Investors, LLC 365,415$3,029,0000.56%
GLOBEFLEX CAPITAL L P 304,515$2,524,0000.51%
View complete list of CATALYST PHARMACEUTICALS INC shareholders